Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michael Lauw"'
Publikováno v:
International Journal of Electronics and Communications System, Vol 3, Iss 2, Pp 57-67 (2023)
The increasing use of the internet makes the implementation process more accessible, but the problem is that it is difficult to manage network management, with the emergence of container technologies such as Docker and Podman as efficient application
Externí odkaz:
https://doaj.org/article/e560c671985b4abfbf49ea53f4817c8d
Autor:
Husain, Sirojul Hadi, Muhammad Haris Nasri, Tomi Tri Sujaka, Lilik Widyawati, Bambang Krismono Triwijoyo, Christopher Michael Lauw
Publikováno v:
TRIDARMA: Pengabdian Kepada Masyarakat (PkM); Vol. 5 No. 2 (2022): Nopember: Pengabdian Kepada Masyarakat (PkM); 389-396
Perkembangan teknolgi infromasi saat ini yang serba digitalisasi mendorong UMKM Fitri Mutiara Lombok dalam memasarkan produk UMKM nya secara online. Menurunnya penjualan secara langsung yang salah satu disebabkan terjadinya pandemic covid 19 mendoron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=ec830ca20f1b::b84d11af2318994c4126507541b6606d
https://iocscience.org/ejournal/index.php/abdimas/article/view/3350
https://iocscience.org/ejournal/index.php/abdimas/article/view/3350
Autor:
Michael Lauw, Thomas Ottoboni, Kimberly Manhard, Barry D. Quart, Neil J. Clendeninn, Matt Cravets, Mary Rose Keller
Publikováno v:
Future oncology (London, England). 15(8)
Aim: HTX-019 (CINVANTI® [aprepitant injectable emulsion]) is a neurokinin 1 receptor antagonist approved for preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV). HTX-019 is free of polysorbate 80 and other synthetic surfacta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320ce5d8400f647ab1297a4dc601e883
https://pubmed.ncbi.nlm.nih.gov/32631101
https://pubmed.ncbi.nlm.nih.gov/32631101
Autor:
Barbara K. Burton, Wuh-Liang Hwu, Yin-Hsiu Chien, Lock Hock Ngu, Nicola Longo, Michael Lauw, John J. Mitchell, Wayne Pan, Uma Ramaswami, Nathalie Guffon
Publikováno v:
Molecular Genetics and Metabolism. 129:S112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abdf070e27fe2b18045b521bfe50cbd5
https://doi.org/10.1016/j.ymgme.2019.11.287
https://doi.org/10.1016/j.ymgme.2019.11.287
Autor:
Lock Hock Ngu, Barbara K. Burton, Michael Lauw, Uma Ramaswami, Wayne Pan, Nicola Longo, Nathalie Guffon, Wuh-Liang Hwu, Yin-Hsiu Chien, John J. Mitchell
Publikováno v:
Molecular Genetics and Metabolism. 129:S36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96b8356b13c37452e8314c09fbcb9208
https://doi.org/10.1016/j.ymgme.2019.11.069
https://doi.org/10.1016/j.ymgme.2019.11.069
Autor:
Kimberly Manhard, Michael Lauw, Mary Rose Keller, Neil J. Clendeninn, Barry D. Quart, Tom Ottoboni, Matt Cravets
Publikováno v:
Future oncology (London, England). 14(27)
Aim: Evaluate safety of HTX-019, a novel polysorbate 80– and synthetic surfactant-free intravenous formulation of neurokinin 1 receptor antagonist aprepitant for chemotherapy-induced nausea and vomiting. Methods: Two open-label, randomized, two-way
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b5973984e314efed0fdfb9df1482e1
https://pubmed.ncbi.nlm.nih.gov/29873529
https://pubmed.ncbi.nlm.nih.gov/29873529